Mark Alvino insider trades: Abeona Therapeutics (ABEO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | ABEO | ↓ Sell | 15,000 | $5.86 | $88K | Direct | Sep 1, 2026 (0d) |
| May 22, 2026 | ABEO | ↓ Sell | 6,500 | $5.46 | $35K | Direct | May 22, 2026 (0d) |
| Feb 2, 2026 | ABEO | ↓ Sell | 2,000 | $5.09 | $10K | Direct | Feb 2, 2026 (0d) |
| Jan 21, 2026 | ABEO | ↓ Sell | 13,500 | $5.23 | $71K | Direct | Jan 21, 2026 (0d) |
| Nov 13, 2025 | ABEO | ↓ Sell | 15,000 | $4.74 | $71K | Direct | Nov 14, 2025 (1d) |
| Jul 9, 2025 | ABEO | ↓ Sell | 13,093 | $5.86 | $77K | Direct | Jul 10, 2025 (1d) |
| May 27, 2025 | ABEO | ↓ Sell | 2,000 | $6.38 | $13K | Direct | May 27, 2025 (0d) |
| May 16, 2025 | ABEO | ↓ Sell | 8,000 | $5.68 | $45K | Direct | May 16, 2025 (0d) |
| Jan 29, 2025 | ABEO | ↓ Sell | 4,000 | $5.38 | $22K | Direct | Jan 31, 2025 (2d) |
| Jan 21, 2025 | ABEO | ↓ Sell | 4,000 | $5.10 | $20K | Direct | Jan 21, 2025 (0d) |
| Jun 18, 2024 | ABEO | ↓ Sell | 25,890 | $4.51 | $117K | Direct | Jun 20, 2024 (2d) |
| Jan 17, 2024 | ABEO | ↓ Sell | 7,084 | $5.11 | $36K | Direct | Jan 22, 2024 (5d) |
| Sep 27, 2023 | ABEO | ↓ Sell | 6,316 | $3.91 | $25K | Direct | Sep 29, 2023 (2d) |
| Apr 25, 2023 | ABEO | ↓ Sell | 887 | $3.25 | $3K | Direct | May 5, 2023 (10d) |
| Jun 15, 2022 | ABEO | ↓ Sell | 20,000 | $0.15 | $3K | Direct | Jun 17, 2022 (2d) |
| Jun 6, 2022 | ABEO | ↓ Sell | 35,000 | $0.16 | $5K | Direct | Jun 7, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ABEO insiders
Open-market trades in the last 12 months
About Mark Alvino's insider trades
Mark Alvino is a director at Abeona Therapeutics (ABEO). Since Jun 6, 2022, Mark has reported no open-market purchases and 16 sales worth $641K on SEC Form 4. In the last 12 months: 5 sales ($275K).
Their filings also include grants and awards (14 filings), gifts (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.